These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4589191)

  • 1. [Controlled evaluation of treatment with an antianginous drug of patients with coronary disease].
    Alberto S; Lavarino A
    Minerva Cardioangiol; 1973 Oct; 21(10):672-6. PubMed ID: 4589191
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy of angina pectoris with propranolol and long-acting nitrates.
    Goldbarg AN; Moran JF; Butterfield TK; Nemickas R; Bermudez GA
    Circulation; 1969 Dec; 40(6):847-53. PubMed ID: 4988122
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preliminary study on the antianginous and antiarrhythmic efficacy of a new benzofuran derivative: amiodarone].
    Gisonni P; Perrone N; Varriale A; Pessetti G
    Minerva Cardioangiol; 1974 Feb; 22(2):134-7. PubMed ID: 4594905
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind trial of hexobendine in the treatment of angina pectoris.
    Rosenstrauch WJ; Bosman AR; Brink AJ
    S Afr Med J; 1968 Aug; 42(31):818-9. PubMed ID: 4878931
    [No Abstract]   [Full Text] [Related]  

  • 5. [Methods o clinical evaluation of therapeutic agents for the treatment of angina pectoris].
    Mabuchi G
    Nihon Ika Daigaku Zasshi; 1970; 37(5):343-58. PubMed ID: 4923115
    [No Abstract]   [Full Text] [Related]  

  • 6. [Review of the literature and report of experiments relating to the coronaroactive drug, hexobendine].
    Marmo E; Caputi AP; Cataldi S
    Minerva Cardioangiol; 1972 Oct; 20(10):571-81. PubMed ID: 4562623
    [No Abstract]   [Full Text] [Related]  

  • 7. [Importance of the placebo in the clinical evaluation of so-called coronary vasodilator agents in patients with clinical manifestations of angina pectoris].
    Calandre L; Ruano JM
    Rev Esp Cardiol; 1965 Apr; 18(2):168-72. PubMed ID: 5319557
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Effects of perhexiline maleate in angina pectoris: a double-blind clinical evaluation with ECG-treadmill exercise testing.
    Morledge J
    Postgrad Med J; 1973 Apr; 49():Suppl 3:64-7. PubMed ID: 4587034
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of stable angina and unstable angina in the elderly with coronary artery disease.
    Olson HG; Aronow WS
    Clin Geriatr Med; 1996 Feb; 12(1):121-40. PubMed ID: 8653654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of a new anti-angina pectoris agent: Fenalcomine hydrochloride].
    ?Warembourg H; Thery C
    Lille Med; 1975 Jan; 20(1):79-82. PubMed ID: 1134178
    [No Abstract]   [Full Text] [Related]  

  • 12. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
    Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
    Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical trials of anti-angina drugs].
    Camerini E; Alberti E; Borgioni L; Medugno G; Scardi S
    G Ital Cardiol; 1976; 6(7):1291-304. PubMed ID: 13024
    [No Abstract]   [Full Text] [Related]  

  • 14. [New drug (Sensit) for the treatment of coronary disease in a double blind test].
    Pillen D
    Fortschr Med; 1974 Jun; 92(16):709-11. PubMed ID: 4600940
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy of angina pectoris with propranolol and long-acting nitrates.
    Goldbarg AN; Morgan JF; Butterfield TK; Nemickas R; Bermudez GA
    Circulation; 1969 Dec; 40(6):847-53. PubMed ID: 4990005
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical trial of a new anti-anginal drug: 2-benzofuryl-p-chlorophenyl carbinol (clobenfurol)].
    Abate G; Cuccurullo F; Curti A
    Minerva Cardioangiol; 1973 Feb; 21(2):145-53. PubMed ID: 4572419
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical trial of the new coronary dilator hexobendine].
    Henke C; Dudik E; Steim H
    Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101
    [No Abstract]   [Full Text] [Related]  

  • 18. [Functional dynamics of ischemic heart disease patients with stable stenocardia as affected by drug treatment].
    Sidorenko BA; Lupanov VP; Kulikova TV; Nekrutman EA; Matveeva LS
    Klin Med (Mosk); 1984 Nov; 62(11):44-51. PubMed ID: 6151611
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical research on the therapeutic efficacy and tolerance of long-acting efloxate in angina pectoris].
    Tomasi AM; Masoni A
    Clin Ter; 1977 Aug; 82(3):227-41. PubMed ID: 334448
    [No Abstract]   [Full Text] [Related]  

  • 20. [Perhexiline maleate in angina pectoris. Study of tolerance to treadmill exercise].
    Souza AD
    Arq Bras Cardiol; 1973 Aug; 26 Suppl 1():83-8. PubMed ID: 4595480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.